More From Our Sponsor:
CompassRx

SPONSORED CONTENT

Despite a number of state laws protecting 340B covered entities (CEs) access to contract pharmacies, lawsuits by manufacturers, court decisions, and pending appeals create significant uncertainty for these entities. These contract pharmacy restrictions can limit access to important 340B medications and

SPONSORED CONTENT

340B teams are facing ever-rising expectations and workloads. Programs must juggle core operational responsibilities while continuously adapting to evolving policies and regulatory changes (especially as we’ve experienced over the

SPONSORED CONTENT

Covered entities do incredible work for their patients every day. The 340B program plays a critical role in helping them do that by stretching scarce resources to expand care, providing medications, and strengthening community health.

SPONSORED CONTENT

The 340B program is facing a period of unprecedented change. With the Inflation Reduction Act (IRA) and Medicare’s Maximum Fair Price (MFP) provisions set to take effect in 2026, covered entities can expect significant shifts—most notably, reduced drug reimbursement and

SPONSORED CONTENT

At the 340B Coalition winter conference in February, two major topics were impossible

SPONSORED CONTENT

What is AI?

Artificial Intelligence (AI) has become a buzzword in nearly every industry, but